CIRM Funded Clinical Trials
A Phase I Study of Multiple doses of NSC-Based Oncolytic Virotherapy Administered Intracerebrally to Patients with Recurrent High-Grade Gliomas
Disease Area:
Trial Sponsor:
Beckman Research Institute of City of Hope
Trial Stage:
Phase 1
Trial Status:
Launching
Targeted Enrollment:
N/A
